Market Overview

Valeant Pharmaceuticals International, Inc. (NYSE: VRX)

8.64 +0.13 (1.53%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/15/16Morgan StanleyDowngradesEqual-Weight17.0
11/23/16MizuhoDowngradesUnderperform11.0
11/10/16Morgan StanleyMaintainsOverweight25.0
11/10/16Rodman & RenshawDowngradesNeutral23.0
9/20/16Deutsche BankInitiates Coverage onHold
8/17/16Morgan StanleyUpgradesOverweight42.0
8/15/16MizuhoUpgradesNeutral
8/09/16Rodman & RenshawMaintainsBuy81.0
6/29/16BMO CapitalInitiates Coverage onMarket Perform
6/23/16JP MorganDowngradesNeutral35.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter